Related Experiment Video
Updated: Jul 15, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Treatment of arterial ischemic stroke in children
Jessica Carpenter1, Tammy Tsuchida, John Kylan Lynch
1Children's National Medical Center, Department of Neurology, Washington, DC 20010, USA. jcarpent@cnmc.org
Insights
Pediatric arterial ischemic stroke is a growing concern. Current treatments, including antiplatelet and antithrombotic agents, are based on limited pediatric data, highlighting the need for dedicated research.
Area of Science:
- Neurology
- Pediatrics
- Vascular Medicine
Background:
- Stroke in children, while rare, is increasingly recognized.
- Current treatment strategies for pediatric arterial ischemic stroke are primarily derived from adult studies, case studies, and expert opinions.
- Existing therapies include thrombolytic, antithrombotic, and antiplatelet agents, blood transfusion, and surgery.
Purpose of the Study:
- To summarize current treatment strategies for pediatric arterial ischemic stroke.
- To highlight the limitations of existing evidence and the need for pediatric-specific research.
- To introduce an ongoing international study investigating pediatric stroke.
Main Methods:
- Review of current therapeutic approaches for pediatric arterial ischemic stroke.
- Discussion of treatment modalities based on adult data and expert consensus.
- Mention of ongoing international research efforts.
Main Results:
- Antiplatelet and antithrombotic agents are the most common treatments for pediatric arterial ischemic stroke, similar to adults.
- Thrombolytic agents are used more frequently but still less than antiplatelet/antithrombotic therapies.
- Sickle-cell disease patients represent a unique subset treated primarily with transfusion therapy.
Conclusions:
- There is a critical need for dedicated pediatric arterial ischemic stroke studies to establish optimal treatment protocols.
- Current treatment relies heavily on extrapolation from adult data, necessitating further pediatric-focused research.
- An international study is underway to comprehensively evaluate pediatric stroke incidence, risk factors, treatments, and outcomes.
Abstract:
Stroke is a rare but increasingly recognized disorder in children. Current therapies for arterial ischemic stroke include thrombolytic, antithrombotic and antiplatelet agents, blood transfusion and surgery. Adult studies, pediatric case studies and expert opinion form the basis for these treatment strategies. Thrombolytic agents are increasingly used but, as in adults, the majority of arterial ischemic strokes in children are treated with antiplatelet and antithrombotic agents. Sickle-cell patients, a distinct subset of the pediatric stroke population, are treated primarily with transfusion therapy. Pediatric arterial ischemic stroke studies are needed to determine the most appropriate course of treatment. An international study is currently in progress to formally study the incidence, risk factors, treatment strategies and outcomes of stroke in children.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
